Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthrax”

80 trials

Showing 20 of 80 results

Early research (Phase 1)Study completedNCT01280175
What this trial is testing

Foster With or Without Charcoal Block or Aerochamber Plus

Who this might be right for
Healthy Volunteers
Chiesi Farmaceutici S.p.A. 13
Early research (Phase 1)Study completedNCT00063843
What this trial is testing

Anthrax-rPA: Safety, Tolerability, Immunogenicity

Who this might be right for
Anthrax
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT02177721
What this trial is testing

Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario

Who this might be right for
Infections, Bacterial
Emergent BioSolutions 100
Early research (Phase 1)Study completedNCT01867957
What this trial is testing

Efficacy and Safety of Anthrax Vaccine, GC1109

Who this might be right for
Anthrax
Seoul National University Hospital 20
Not applicableStudy completedNCT01653392
What this trial is testing

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

Who this might be right for
Pregnancy ComplicationsPregnancy OutcomeCongenital Abnormalities
Emergent BioSolutions 98
Early research (Phase 1)Study completedNCT00138411
What this trial is testing

Monoclonal Antibody for Treatment of Inhalation Anthrax

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT01263691
What this trial is testing

Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults

Who this might be right for
Bacillus Anthracis (Anthrax) Infection
Emergent BioSolutions 105
Early research (Phase 1)Study completedNCT01952444
What this trial is testing

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 40
Early research (Phase 1)Study completedNCT01979406
What this trial is testing

Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines

Who this might be right for
Anthrax Infection
Emergent BioSolutions 120
Very early researchStudy completedNCT04204772
What this trial is testing

A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers

Who this might be right for
Healthy Adult Volunteers
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT01265745
What this trial is testing

Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects

Who this might be right for
Anthrax
PharmAthene, Inc. 28
Not applicableEnded earlyNCT05672875
What this trial is testing

Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

Who this might be right for
Anthrax
SRI International 343
Not applicableNot Yet RecruitingNCT03569553
What this trial is testing

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

Who this might be right for
Inhalational Anthrax
Emergent BioSolutions 100
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Not applicableStudy completedNCT00123396
What this trial is testing

VHA Clinicians and Bioterror Events: Interactive Web-based Learning

Who this might be right for
SmallpoxAnthrax
US Department of Veterans Affairs 15
Large-scale testing (Phase 3)Study completedNCT01491607
What this trial is testing

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Anthrax
Emergent BioSolutions 200
Early research (Phase 1)Study completedNCT02655549
What this trial is testing

Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects

Who this might be right for
Anthrax
Pfenex, Inc 54
Early research (Phase 1)Study completedNCT01932437
What this trial is testing

Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 36
Early research (Phase 1)Study completedNCT02239172
What this trial is testing

PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine

Who this might be right for
Anthrax
Fraunhofer, Center for Molecular Biotechnology 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07201311
What this trial is testing

Combined Gastrointestinal Decontamination in Acute Severe Poisoning

Who this might be right for
Severe Poisoning With Cardiotropic or Psychotropic DrugAdmission to Intensive Care
Assistance Publique - Hôpitaux de Paris 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation